These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 29295756)
1. A virus-like particle vaccine confers protection against enterovirus D68 lethal challenge in mice. Dai W; Zhang C; Zhang X; Xiong P; Liu Q; Gong S; Geng L; Zhou D; Huang Z Vaccine; 2018 Jan; 36(5):653-659. PubMed ID: 29295756 [TBL] [Abstract][Full Text] [Related]
2. Enterovirus D68 virus-like particles expressed in Pichia pastoris potently induce neutralizing antibody responses and confer protection against lethal viral infection in mice. Zhang C; Zhang X; Zhang W; Dai W; Xie J; Ye L; Wang H; Chen H; Liu Q; Gong S; Geng L; Huang Z Emerg Microbes Infect; 2018 Jan; 7(1):3. PubMed ID: 29323105 [TBL] [Abstract][Full Text] [Related]
3. A virus-like particle vaccine protects mice against coxsackievirus A10 lethal infection. Zhou Y; Zhang C; Liu Q; Gong S; Geng L; Huang Z Antiviral Res; 2018 Apr; 152():124-130. PubMed ID: 29470994 [TBL] [Abstract][Full Text] [Related]
4. Immunogenicity and performance of an enterovirus 71 virus-like-particle vaccine in nonhuman primates. Lim PY; Hickey AC; Jamiluddin MF; Hamid S; Kramer J; Santos R; Bossart KN; Cardosa MJ Vaccine; 2015 Nov; 33(44):6017-24. PubMed ID: 26271825 [TBL] [Abstract][Full Text] [Related]
5. A neonatal mouse model of Enterovirus D68 infection induces both interstitial pneumonia and acute flaccid myelitis. Sun S; Bian L; Gao F; Du R; Hu Y; Fu Y; Su Y; Wu X; Mao Q; Liang Z Antiviral Res; 2019 Jan; 161():108-115. PubMed ID: 30503887 [TBL] [Abstract][Full Text] [Related]
6. A Mouse Model of Enterovirus D68 Infection for Assessment of the Efficacy of Inactivated Vaccine. Zhang C; Zhang X; Dai W; Liu Q; Xiong P; Wang S; Geng L; Gong S; Huang Z Viruses; 2018 Jan; 10(2):. PubMed ID: 29385753 [TBL] [Abstract][Full Text] [Related]
7. Virus-like particle-based vaccine against coxsackievirus A6 protects mice against lethal infections. Shen C; Ku Z; Zhou Y; Li D; Wang L; Lan K; Liu Q; Huang Z Vaccine; 2016 Jul; 34(34):4025-31. PubMed ID: 27340093 [TBL] [Abstract][Full Text] [Related]
8. A Novel Neutralizing Antibody Specific to the DE Loop of VP1 Can Inhibit EV-D68 Infection in Mice. Zheng H; Wang J; Li B; Guo L; Li H; Song J; Yang Z; Li H; Fan H; Huang X; Long H; Cheng C; Chu M; He Z; Yu W; Li J; Gao Y; Ning R; Li N; Yang J; Wu Q; Shi H; Sun M; Liu L J Immunol; 2018 Nov; 201(9):2557-2569. PubMed ID: 30282753 [TBL] [Abstract][Full Text] [Related]
9. Induction of a high-titered antibody response using HIV gag-EV71 VP1-based virus-like particles with the capacity to protect newborn mice challenged with a lethal dose of enterovirus 71. Wang X; Dong K; Long M; Lin F; Gao Z; Wang L; Zhang Z; Chen X; Dai Y; Wang H; Zhang H Arch Virol; 2018 Jul; 163(7):1851-1861. PubMed ID: 29582164 [TBL] [Abstract][Full Text] [Related]
10. Combination of three virus-derived nanoparticles as a vaccine against enteric pathogens; enterovirus, norovirus and rotavirus. Heinimäki S; Hankaniemi MM; Sioofy-Khojine AB; Laitinen OH; Hyöty H; Hytönen VP; Vesikari T; Blazevic V Vaccine; 2019 Dec; 37(51):7509-7518. PubMed ID: 31585726 [TBL] [Abstract][Full Text] [Related]
11. A virus-like particle based bivalent vaccine confers dual protection against enterovirus 71 and coxsackievirus A16 infections in mice. Ku Z; Liu Q; Ye X; Cai Y; Wang X; Shi J; Li D; Jin X; An W; Huang Z Vaccine; 2014 Jul; 32(34):4296-303. PubMed ID: 24950363 [TBL] [Abstract][Full Text] [Related]
12. Vesicular stomatitis virus-based vaccines expressing EV71 virus-like particles elicit strong immune responses and protect newborn mice from lethal challenges. Yan Q; Wu L; Chen L; Qin Y; Pan Z; Chen M Vaccine; 2016 Jul; 34(35):4196-4204. PubMed ID: 27373596 [TBL] [Abstract][Full Text] [Related]
14. A virus-like particle vaccine for coxsackievirus A16 potently elicits neutralizing antibodies that protect mice against lethal challenge. Liu Q; Yan K; Feng Y; Huang X; Ku Z; Cai Y; Liu F; Shi J; Huang Z Vaccine; 2012 Oct; 30(47):6642-8. PubMed ID: 22959985 [TBL] [Abstract][Full Text] [Related]
15. EV-D68 virus-like particle vaccines elicit cross-clade neutralizing antibodies that inhibit infection and block dissemination. Krug PW; Wang L; Shi W; Kong WP; Moss DL; Yang ES; Fisher BE; Morabito KM; Mascola JR; Kanekiyo M; Graham BS; Ruckwardt TJ Sci Adv; 2023 May; 9(20):eadg6076. PubMed ID: 37196074 [TBL] [Abstract][Full Text] [Related]
16. EV71 virus-like particles produced by co-expression of capsid proteins in yeast cells elicit humoral protective response against EV71 lethal challenge. Wang X; Xiao X; Zhao M; Liu W; Pang L; Sun X; Cen S; Yang BB; Huang Y; Sheng W; Zeng Y BMC Res Notes; 2016 Jan; 9():42. PubMed ID: 26809443 [TBL] [Abstract][Full Text] [Related]
17. Recombinant virus-like particle presenting a newly identified coxsackievirus A10 neutralization epitope induces protective immunity in mice. Dai W; Xiong P; Zhang X; Liu Z; Chen J; Zhou Y; Ye X; Zhang C Antiviral Res; 2019 Apr; 164():139-146. PubMed ID: 30817941 [TBL] [Abstract][Full Text] [Related]
18. Protective effect of enterovirus‑71 (EV71) virus‑like particle vaccine against lethal EV71 infection in a neonatal mouse model. Cao L; Mao F; Pang Z; Yi Y; Qiu F; Tian R; Meng Q; Jia Z; Bi S Mol Med Rep; 2015 Aug; 12(2):2473-80. PubMed ID: 25936344 [TBL] [Abstract][Full Text] [Related]
19. Current Understanding of Humoral Immunity to Enterovirus D68. Vogt MR; Crowe JE J Pediatric Infect Dis Soc; 2018 Dec; 7(suppl_2):S49-S53. PubMed ID: 30590621 [TBL] [Abstract][Full Text] [Related]
20. An Envelope-Modified Tetravalent Dengue Virus-Like-Particle Vaccine Has Implications for Flavivirus Vaccine Design. Urakami A; Ngwe Tun MM; Moi ML; Sakurai A; Ishikawa M; Kuno S; Ueno R; Morita K; Akahata W J Virol; 2017 Dec; 91(23):. PubMed ID: 28956764 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]